Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New test developed to diagnose Brucella canis
The new test is able to measure antibody levels.
The CBM assay is already being used in the USA.

Researchers have developed a new diagnostic test for Brucella canis that is able to measure the number of antibodies in infected dogs.

In contrast to previous tests, which could only detect whether or not antibodies were present, the new Canine Brucella Multiplex (CBM) assay makes it possible to monitor how an infected dog is responding to treatment.

However, a reduction in the number of antibodies does not necessarily mean that the infection is no longer present, as it can be sequestered in tissue.

Created by researchers at the Cornell University College of Veterinary Medicine (CVM), the test is already being used to diagnose dogs in the USA, where up to six per cent of dogs are affected by the disease.

Dr Toby Pinn-Woodcock, an assistant clinical professor at CVM, said: “We’re testing hundreds of dogs per month. We believe that this test is more sensitive and less prone to false-positive results.”

Although Brucella canis is not currently endemic in the UK, there has been a spike in cases of the zoonotic disease since 2020, with cases found in dogs imported from Europe and elsewhere. In 2022, 54 cases were reported, along with the first recorded case of dog-to-human transmission in the UK.

In February, the BSAVA published a Scientific Information Document to provide veterinary professionals with information about the disease. Currently, euthanasia of infected dogs is considered the only way to prevent any risk of transmission, although there are steps that can be taken to try to reduce the risk of transmission when owners choose not to euthanise.

Following the development of the new test, the researchers at CVM are seeking funding to study whether a prolonged decrease in the amount of antibodies could be a sign that a dog is cured of the disease.

Cassandra Guarino, assistant professor at CVM, said: “In theory, if the [antibody] values come down and stay down for a certain amount of time, we may be able to say with confidence that the animal has successfully cleared the infection, but we’re not quite there yet.”

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.